These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8515683)

  • 1. Regional homovanillic acid production in humans.
    Lambert GW; Eisenhofer G; Jennings GL; Esler MD
    Life Sci; 1993; 53(1):63-75. PubMed ID: 8515683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional 5-hydroxyindoleacetic acid production in humans.
    Lambert GW; Kaye DM; Cox HS; Vaz M; Turner AG; Jennings GL; Esler MD
    Life Sci; 1995; 57(3):255-67. PubMed ID: 7541101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation.
    Lambert GW; Kaye DM; Vaz M; Cox HS; Turner AG; Jennings GL; Esler MD
    J Auton Nerv Syst; 1995 Nov; 55(3):169-78. PubMed ID: 8801267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity.
    Lambert GW; Eisenhofer G; Cox HS; Horne M; Kalff V; Kelly M; Jennings GL; Esler MD
    Life Sci; 1991; 49(15):1061-72. PubMed ID: 1895870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of aging on the plasma concentration and renal clearance of homovanillic acid.
    Lambert GW; Eisenhofer G; Esler MD
    Psychoneuroendocrinology; 1994; 19(1):33-41. PubMed ID: 9210210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoaminergic neuronal activity in subcortical brain regions in essential hypertension.
    Lambert GW; Ferrier C; Kaye DM; Kalff V; Kelly MJ; Cox HS; Turner AG; Jennings GL; Esler MD
    Blood Press; 1994 Mar; 3(1-2):55-66. PubMed ID: 7515310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of renal clearance on peripheral homovanillic acid measurements in healthy subjects and schizophrenic patients.
    Whelton CL; Gupta RN; Cleghorn JM; Ballagh SR
    Schizophr Res; 1993 Dec; 11(1):33-40. PubMed ID: 8297802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain contribution to the haloperidol-induced increase in plasma homovanillic acid.
    Kendler KS; Heninger GR; Roth RH
    Eur J Pharmacol; 1981 May; 71(2-3):321-6. PubMed ID: 7250191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma homovanillic acid as an index of brain dopamine metabolism: enhancement with debrisoquin.
    Sternberg DE; Heninger GR; Roth RH
    Life Sci; 1983 May; 32(21):2447-52. PubMed ID: 6855448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients.
    Pickar D; Breier A; Kelsoe J
    Ann N Y Acad Sci; 1988; 537():339-46. PubMed ID: 2904783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
    Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
    Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
    Pestana M; Jardim H; Correia F; Vieira-Coelho MA; Soares-da-Silva P
    Nephrol Dial Transplant; 2001; 16 Suppl 1():53-9. PubMed ID: 11369822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautions.
    Potter WZ; Hsiao JK; Goldman SM
    Arch Gen Psychiatry; 1989 Jun; 46(6):558-62. PubMed ID: 2730280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system noradrenergic and dopaminergic turnover in response to acute neuroleptic challenge.
    Lambert GW; Horne M; Kalff V; Kelly MJ; Turner AG; Cox HS; Jennings GL; Esler MD
    Life Sci; 1995; 56(19):1545-55. PubMed ID: 7723582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of renal factors in plasma homovanillic acid measurements.
    Amin F; Stroe AE; Kahn T; Knott PJ; Kahn RS; Davidson M
    Neuropsychopharmacology; 1998 Apr; 18(4):317-20. PubMed ID: 9509499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.
    Konicki PE; Owen RR; Litman RE; Pickar D
    Life Sci; 1991; 48(14):1411-6. PubMed ID: 2008157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects.
    Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ
    J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dopamine agonists on plasma and brain levels of homovanillic acid.
    Kendler KS; Heninger GR; Roth RH
    Life Sci; 1982 Jun; 30(24):2063-9. PubMed ID: 7109836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homovanillic acid and performance on motor and cognitive tasks in community-dwelling elderly: MacArthur studies of successful aging.
    Amin F; Seeman TE; Mohs RC; Davidson M; Knott P; Berkman LF; Albert M; Blazer D
    Neuropsychopharmacology; 1994 Feb; 10(1):29-35. PubMed ID: 8179792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid.
    Ebinger G; Michotte Y; Herregodts P
    J Neurochem; 1987 Jun; 48(6):1725-9. PubMed ID: 3572399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.